Here you find the press releases from Evonik SEAANZ.
The award recognizes Evonik’s strong cell culture ingredients portfolio that includes cQrex® peptides, the plant-based cholesterol PhytoChol®, as well as R&D, formulation and process expertise. ... MORE
In a difficult environment, Evonik has delivered another strong quarter, exceeding analysts' expectations. ... MORE
Evonik had a much better start into 2024 than the capital market had expected. The final results for the first quarter 2024 are now confirmed the preliminary data published April 16. ... MORE
The start into 2024 was better than expected for Evonik. The company is therefore publishing preliminary financials for the first quarter already today. ... MORE
The company received the award for its Cell Culture Solutions portfolio in the category Best New Bioprocessing Supplier Award: Upstream Processing. ... MORE
Evonik met the 2023 forecast the company had reduced in the summer, despite a continuously challenging environment. The specialty chemicals company's adjusted EBITDA amounted to €1.66 billion, within the targeted range of between €1.6 billion and €1.8 billion. ... MORE
